Related references
Note: Only part of the references are listed.A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice
Chun-Hung Liu et al.
HEPATOLOGY (2018)
Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients
Yadong Wang et al.
SCIENTIFIC REPORTS (2017)
Reversal of liver cirrhosis: current evidence and expectations
Young Kul Jung et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Long-Circulating Liposomal Delivery System Targeting at PDGFR-β Enhances the Therapeutic Effect of IFN-α on Hepatic Fibrosis
Qinghua Li et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Roles of hepatic stellate cells in liver inflammation: a new perspective
Tomoko Fujita et al.
INFLAMMATION AND REGENERATION (2016)
Reversibility of liver fibrosis
Mengxi Sun et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy
Mathangi Srinivasan et al.
NANOMATERIALS (2015)
Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma
Nan Lin et al.
HEPATOLOGY RESEARCH (2015)
Macrophage heterogeneity in liver injury and fibrosis
Frank Tacke et al.
JOURNAL OF HEPATOLOGY (2014)
Combination of TRAIL with Bortezomib Shifted Apoptotic Signaling from DR4 to DR5 Death Receptor by Selective Internalization and Degradation of DR4
Maxim L. Bychkov et al.
PLOS ONE (2014)
Inactivation of myofibroblasts during regression of liver fibrosis
Tatiana Kisseleva et al.
CELL CYCLE (2013)
Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies
M. Marconi et al.
CELL DEATH & DISEASE (2013)
Nanoparticle and targeted systems for cancer therapy
Lisa Brannon-Peppas et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats
Feng Li et al.
JOURNAL OF CONTROLLED RELEASE (2012)
NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
Andreas Glaessner et al.
LABORATORY INVESTIGATION (2012)
TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
Christian T. Hellwig et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Novel Engineered Targeted Interferon-gamma Blocks Hepatic Fibrogenesis in Mice
Ruchi Bansal et al.
HEPATOLOGY (2011)
Peptide-Modified Albumin Carrier Explored as a Novel Strategy for a Cell-Specific Delivery of Interferon Gamma To Treat Liver Fibrosis
Ruchi Barisal et al.
MOLECULAR PHARMACEUTICS (2011)
New insights into apoptosis signaling by Apo2L/TRAIL
F. Gonzalvez et al.
ONCOGENE (2010)
Size and Shape of Protein Molecules at the Nanometer Level Determined by Sedimentation, Gel Filtration, and Electron Microscopy
Harold P. Erickson
BIOLOGICAL PROCEDURES ONLINE (2009)
TRAIL induces endocytosis of its death receptors in MDA-MB-231 breast cancer cells
Yaqin Zhang et al.
CANCER BIOLOGY & THERAPY (2009)
PDGF-receptor β-targeted adenovirus redirects gene transfer from hepatocytes to activated stellate cells
Marieke H. Schoemaker et al.
MOLECULAR PHARMACEUTICS (2008)
Pharmacokinetics and biodistribution of nanoparticles
Shyh-Dar Li et al.
MOLECULAR PHARMACEUTICS (2008)
TRAIL in cancer therapy:: present and future challenges
Delphine Merino et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies
M MacFarlane et al.
CANCER RESEARCH (2005)
Effects of interferon-alpha on expression of hepatic stellate cell and transforming growth factor-β1 and α-smooth muscle actin in rats with hepatic fibrosis
Xin-Ming Chang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL
O Aktas et al.
NEURON (2005)
The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue
L Beljaars et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis
P Taimr et al.
HEPATOLOGY (2003)
Death receptor-mediated apoptosis and the liver
JH Yoon et al.
JOURNAL OF HEPATOLOGY (2002)
Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins
AE Tollefson et al.
JOURNAL OF VIROLOGY (2001)
Expression of small heat shock protein αB-crystallin is induced after hepatic stellate cell activation
A Lang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
M Jo et al.
NATURE MEDICINE (2000)
Regulation of signal transduction by endocytosis
BP Ceresa et al.
CURRENT OPINION IN CELL BIOLOGY (2000)
Share Paper
